Drug Profile
U 77863
Alternative Names: 6724A OMCLatest Information Update: 20 Jun 2001
Price :
$50
*
At a glance
- Originator Pharmacia Corporation
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 20 Jun 2001 No-Development-Reported for Cancer in USA (Unknown route)